BioMed Laboratory
 School of Life Sciences
 Nanjing University

Lab-Intro > Publications
Publications
  •   miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12beta during murine colitis and human Crohn\'s disease. Huang, Z., T. Shi, Q. Zhou, S. Shi, R. Zhao, H. Shi, L. Dong, C. Zhang, K. Zeng, J. Chen and J. Zhang. Gut. 2014;63(8):1247-1257.
  •   3,3\'-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expression. Zhang, Z., Z. Gao, W. Hu, S. Yin, C. Wang, Y. Zang, J. Chen, J. Zhang and L. Dong. Br J Pharmacol. 2013;170(3):649-660.
  •   MicroRNAs in osteosarcoma: from biological players to clinical contributors, a review. Zhou, G., X. Shi, J. Zhang, S. Wu and J. Zhao. J Int Med Res. 2013;41(1):1-12.
  •   The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development. Zhang, Z., Y. Zha, W. Hu, Z. Huang, Z. Gao, Y. Zang, J. Chen, L. Dong and J. Zhang. J Biol Chem. 2013;288(52):37082-37093.
  •   Particle-induced osteolysis mediated by endoplasmic reticulum stress in prosthesis loosening. Wang, R., Z. Wang, Y. Ma, G. Liu, H. Shi, J. Chen, L. Dong, J. Zhao and J. Zhang. Biomaterials. 2013;34(11):2611-2623.
  •   MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1). Sun, D., F. Yu, Y. Ma, R. Zhao, X. Chen, J. Zhu, C. Y. Zhang, J. Chen and J. Zhang. J Biol Chem. 2013;288(13):9508-9518.
  •   Locally instilled tumor necrosis factor alpha antisense oligonucleotide contributes to inhibition of TH 2-driven pulmonary fibrosis via induced CD4+ CD25+ Foxp3+ regulatory T cells. Luo, Y., M. Wang, Z. Pang, F. Jiang, J. Chen and J. Zhang. J Gene Med. 2013;15(11-12):441-452.
  •   microRNAs are ligands of Toll-like receptors. Chen, X., H. Liang, J. Zhang, K. Zen and C. Y. Zhang. RNA. 2013;19(6):737-739.
  •   3,3\\\'-Diindolymethane ameliorates adriamycin-induced cardiac fibrosis via activation of a BRCA1-dependent anti-oxidant pathway. Yao, Z., W. Hu, S. Yin, Z. Huang, Q. Zhu, J. Chen, Y. Zang, L. Dong and J. Zhang. Pharmacol Res. 2013;70(1):139-146.
  •   Anti-tumor immune responses of tumor-associated macrophages via toll-like receptor 4 triggered by cationic polymers. Huang, Z., Y. Yang, Y. Jiang, J. Shao, X. Sun, J. Chen, L. Dong and J. Zhang. Biomaterials. 2013;34(3):746-755.
  •   3,3\'-Diindolylmethane alleviates oxazolone-induced colitis through Th2/Th17 suppression and Treg induction. Huang, Z., Y. Jiang, Y. Yang, J. Shao, X. Sun, J. Chen, L. Dong and J. Zhang. Mol Immunol. 2013;53(4):335-344.
  •   Harnessing the power of macrophages/monocytes for enhanced bone tissue engineering. Dong, L. and C. Wang. Trends Biotechnol. 2013;31(6):342-346.
  •   Anti-tumor immune responses of tumor-associated macrophages via toll-like receptor 4 triggered by cationic polymers. Huang Z, Yang Y, Jiang Y, Shao J, Sun X, Chen J, Dong L, Zhang J. Biomaterials. 2013; 34(3): 746-55.
  •   Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F, Wang J, Li L, Zhou X, Li N, Pan H, Zhang J, Zen K, Zhang CY, Zhang C. Int J Cancer. 2013;132(1)
  •   Low-molecular weight chitosan/vascular endothelial growth factor short hairpin RNA for the treatment of hepatocellular carcinoma. Huang Z, Dong L, Chen J, Gao F, Zhang Z, Chen J, Zhang J. Life Sci. 2012;91(23-24):1207-15.
  •   miR-30 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. Zhang, J., H. Zhang, J. Liu, X. Tu, Y. Zang, J. Zhu, J. Chen, L. Dong and J. Zhang. Biochem Biophys Res Commun. 2012;417(3):1100-1105.
  •   Locally instilled tumor necrosis factor-alpha antisense oligonucleotide inhibits allergic inflammation via the induction of Tregs. Luo, Y., Z. Pang, Q. Zhu, X. Cai, Y. Yin, M. Wang, J. Zhu, J. Chen, K. Zeng, C. Zhang and J. Zhang. J Gene Med. 2012;14(6):374-383.
  •   The effect of targeted delivery of anti-TNF-alpha oligonucleotide into CD169+ macrophages on disease progression in lupus-prone MRL/lpr mice. Huang, Z., Z. Zhang, Y. Zha, J. Liu, Y. Jiang, Y. Yang, J. Shao, X. Sun, X. Cai, Y. Yin, J. Chen, L. Dong and J. Zhang. Biomaterials. 2012;33(30):7605-7612.
  •   Preparation and antitumor activity of a polymeric derivative of methotrexate. Zhou, G., X. Cheng, S. Wu, X. Jiang, X. Shi, J. Chen, J. Zhang and J. Zhao. Am J Med Sci. 2012;344(4):294-299.
  •   Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy. Huang, Z., Z. Zhang, Y. Jiang, D. Zhang, J. Chen, L. Dong and J. Zhang. J Control Release. 2012;158(2):286-292.